49 research outputs found
CRISPR-Cas9 screens in human cells and primary neurons identify modifiers of C9ORF72 dipeptide-repeat-protein toxicity.
Hexanucleotide-repeat expansions in the C9ORF72 gene are the most common cause of amyotrophic lateral sclerosis and frontotemporal dementia (c9ALS/FTD). The nucleotide-repeat expansions are translated into dipeptide-repeat (DPR) proteins, which are aggregation prone and may contribute to neurodegeneration. We used the CRISPR-Cas9 system to perform genome-wide gene-knockout screens for suppressors and enhancers of C9ORF72 DPR toxicity in human cells. We validated hits by performing secondary CRISPR-Cas9 screens in primary mouse neurons. We uncovered potent modifiers of DPR toxicity whose gene products function in nucleocytoplasmic transport, the endoplasmic reticulum (ER), proteasome, RNA-processing pathways, and chromatin modification. One modifier, TMX2, modulated the ER-stress signature elicited by C9ORF72 DPRs in neurons and improved survival of human induced motor neurons from patients with C9ORF72 ALS. Together, our results demonstrate the promise of CRISPR-Cas9 screens in defining mechanisms of neurodegenerative diseases
Editing the genome of chicken primordial germ cells to introduce alleles and study gene function
With continuing advances in genome sequencing technology, the chicken genome
assembly is now better annotated with improved accuracy to the level of single
nucleotide polymorphisms. Additionally, the genomes of other birds such as the duck,
turkey and zebra finch have now been sequenced. A great opportunity exists in avian
biology to use genome editing technology to introduce small and defined sequence
changes to create specific haplotypes in chicken to investigate gene regulatory
function, and also perform rapid and seamless transfer of specific alleles between
chicken breeds. The methods for performing such precise genome editing are well
established for mammalian species but are not readily applicable in birds due to
evolutionary differences in reproductive biology.
A significant leap forward to address this challenge in avian biology was the
development of long-term culture methods for chicken primordial germ cells (PGCs).
PGCs present a cell line in which to perform targeted genetic manipulations that will
be heritable. Chicken PGCs have been successfully targeted to generate genetically
modified chickens. However, genome editing to introduce small and defined sequence
changes has not been demonstrated in any avian species. To address this deficit, the
application of CRISPR/Cas9 and short oligonucleotide donors in chicken PGCs for
performing small and defined sequence changes was investigated in this thesis.
Specifically, homology-directed DNA repair (HDR) using oligonucleotide donors
along with wild-type CRISPR/Cas9 (SpCas9-WT) or high fidelity CRISPR/Cas9
(SpCas9-HF1) was investigated in cultured chicken PGCs. The results obtained
showed that small sequences changes ranging from a single to a few nucleotides could
be precisely edited in many loci in chicken PGCs. In comparison to SpCas9-WT,
SpCas9-HF1 increased the frequency of biallelic and single allele editing to generate
specific homozygous and heterozygous genotypes. This finding demonstrates the
utility of high fidelity CRISPR/Cas9 variants for performing sequence editing with
high efficiency in PGCs.
Since PGCs can be converted into pluripotent stem cells that can potentially
differentiate into many cell types from the three germ layers, genome editing of PGCs
can, therefore, be used to generate PGC-derived avian cell types with defined genetic
alterations to investigate the host-pathogen interactions of infectious avian diseases.
To investigate this possibility, the chicken ANP32A gene was investigated as a target
for genetic resistance to avian influenza virus in PGC-derived chicken cell lines.
Targeted modification of ANP32A was performed to generate clonal lines of genome-edited
PGCs. Avian influenza minigenome replication assays were subsequently
performed in the ANP32A-mutant PGC-derived cell lines. The results verified that
ANP32A function is crucial for the function of both avian virus polymerase and
human-adapted virus polymerase in chicken cells. Importantly, an asparagine to
isoleucine mutation at position 129 (N129I) in chicken ANP32A failed to support
avian influenza polymerase function. This genetic change can be introduced into
chickens and validated in virological studies. Importantly, the results of my
investigation demonstrate the potential to use genome editing of PGCs as an approach
to generate many types of unique cell models for the study of avian biology.
Genome editing of PGCs may also be applied to unravel the genes that control the
development of the avian germ cell lineage. In the mouse, gene targeting has been
extensively applied to generate loss-of-function mouse models to use the reverse
genetics approach to identify key genes that regulate the migration of specified PGCs
to the genital ridges. Avian PGCs express similar cytokine receptors as their
mammalian counterparts. However, the factors guiding the migration of avian PGCs
are largely unknown. To address this, CRISPR/Cas9 was used in this thesis to generate
clonal lines of chicken PGCs with loss-of-function deletions in the CXCR4 and c-Kit
genes which have been implicated in controlling mouse PGC migration. The results
showed that CXCR4-deficient PGCs are absent from the gonads whereas c-Kit-deficient
PGCs colonise the developing gonads in reduced numbers and are
significantly reduced or absent from older stages. This finding shows a conserved role
for CXCR4 and c-Kit signalling in chicken PGC development. Importantly, other
genes suspected to be involved in controlling the development of avian germ cells can
be investigated using this approach to increase our understanding of avian reproductive
biology.
Finally, the methods developed in this thesis for editing of the chicken genome may
be applied in other avian species once culture methods for the PGCs from these species
are develope
Charitable Platforms in Global Surgery: A Systematic Review of their Effectiveness, Cost-Effectiveness, Sustainability, and Role Training
Recommended from our members
Combinatorial genetics in liver repopulation and carcinogenesis with a in vivo CRISPR activation platform.
Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 activation (CRISPRa) systems have enabled genetic screens in cultured cell lines to discover and characterize drivers and inhibitors of cancer cell growth. We adapted this system for use in vivo to assess whether modulating endogenous gene expression levels can result in functional outcomes in the native environment of the liver. We engineered the catalytically dead CRISPR-associated 9 (dCas9)-positive mouse, cyclization recombination-inducible (Cre) CRISPRa system for cell type-specific gene activation in vivo. We tested the capacity for genetic screening in live animals by applying CRISPRa in a clinically relevant model of liver injury and repopulation. We targeted promoters of interest in regenerating hepatocytes using multiple single guide RNAs (gRNAs), and employed high-throughput sequencing to assess enrichment of gRNA sequences during liver repopulation and to link specific gRNAs to the initiation of carcinogenesis. All components of the CRISPRa system were expressed in a cell type-specific manner and activated endogenous gene expression in vivo. Multiple gRNA cassettes targeting a proto-oncogene were significantly enriched following liver repopulation, indicative of enhanced division of cells expressing the proto-oncogene. Furthermore, hepatocellular carcinomas developed containing gRNAs that activated this oncogene, indicative of cancer initiation events. Also, we employed our system for combinatorial cancer genetics in vivo as we found that while clonal hepatocellular carcinomas were dependent on the presence of the oncogene-inducing gRNAs, they were depleted for multiple gRNAs activating tumor suppressors.ConclusionThe in vivo CRISPRa platform developed here allows for parallel and combinatorial genetic screens in live animals; this approach enables screening for drivers and suppressors of cell replication and tumor initiation. (Hepatology 2017)
Prostate cancer research: The next generation; report from the 2019 Coffey‐Holden Prostate Cancer Academy Meeting
IntroductionThe 2019 Coffey-Holden Prostate Cancer Academy (CHPCA) Meeting, "Prostate Cancer Research: The Next Generation," was held 20 to 23 June, 2019, in Los Angeles, California.MethodsThe CHPCA Meeting is an annual conference held by the Prostate Cancer Foundation, that is uniquely structured to stimulate intense discussion surrounding topics most critical to accelerating prostate cancer research and the discovery of new life-extending treatments for patients. The 7th Annual CHPCA Meeting was attended by 86 investigators and concentrated on many of the most promising new treatment opportunities and next-generation research technologies.ResultsThe topics of focus at the meeting included: new treatment strategies and novel agents for targeted therapies and precision medicine, new treatment strategies that may synergize with checkpoint immunotherapy, next-generation technologies that visualize tumor microenvironment (TME) and molecular pathology in situ, multi-omics and tumor heterogeneity using single cells, 3D and TME models, and the role of extracellular vesicles in cancer and their potential as biomarkers.DiscussionThis meeting report provides a comprehensive summary of the talks and discussions held at the 2019 CHPCA Meeting, for the purpose of globally disseminating this knowledge and ultimately accelerating new treatments and diagnostics for patients with prostate cancer
A high-throughput screen of real-time ATP levels in individual cells reveals mechanisms of energy failure.
Insufficient or dysregulated energy metabolism may underlie diverse inherited and degenerative diseases, cancer, and even aging itself. ATP is the central energy carrier in cells, but critical pathways for regulating ATP levels are not systematically understood. We combined a pooled clustered regularly interspaced short palindromic repeats interference (CRISPRi) library enriched for mitochondrial genes, a fluorescent biosensor, and fluorescence-activated cell sorting (FACS) in a high-throughput genetic screen to assay ATP concentrations in live human cells. We identified genes not known to be involved in energy metabolism. Most mitochondrial ribosomal proteins are essential in maintaining ATP levels under respiratory conditions, and impaired respiration predicts poor growth. We also identified genes for which coenzyme Q10 (CoQ10) supplementation rescued ATP deficits caused by knockdown. These included CoQ10 biosynthetic genes associated with human disease and a subset of genes not linked to CoQ10 biosynthesis, indicating that increasing CoQ10 can preserve ATP in specific genetic contexts. This screening paradigm reveals mechanisms of metabolic control and genetic defects responsive to energy-based therapies
Recommended from our members
A high-throughput screen of real-time ATP levels in individual cells reveals mechanisms of energy failure.
Insufficient or dysregulated energy metabolism may underlie diverse inherited and degenerative diseases, cancer, and even aging itself. ATP is the central energy carrier in cells, but critical pathways for regulating ATP levels are not systematically understood. We combined a pooled clustered regularly interspaced short palindromic repeats interference (CRISPRi) library enriched for mitochondrial genes, a fluorescent biosensor, and fluorescence-activated cell sorting (FACS) in a high-throughput genetic screen to assay ATP concentrations in live human cells. We identified genes not known to be involved in energy metabolism. Most mitochondrial ribosomal proteins are essential in maintaining ATP levels under respiratory conditions, and impaired respiration predicts poor growth. We also identified genes for which coenzyme Q10 (CoQ10) supplementation rescued ATP deficits caused by knockdown. These included CoQ10 biosynthetic genes associated with human disease and a subset of genes not linked to CoQ10 biosynthesis, indicating that increasing CoQ10 can preserve ATP in specific genetic contexts. This screening paradigm reveals mechanisms of metabolic control and genetic defects responsive to energy-based therapies
Let-7a Is a Direct EWS-FLI-1 Target Implicated in Ewing's Sarcoma Development.
Ewing's sarcoma family tumors (ESFT) are the second most common bone malignancy in children and young adults, characterized by unique chromosomal translocations that in 85% of cases lead to expression of the EWS-FLI-1 fusion protein. EWS-FLI-1 functions as an aberrant transcription factor that can both induce and suppress members of its target gene repertoire. We have recently demonstrated that EWS-FLI-1 can alter microRNA (miRNA) expression and that miRNA145 is a direct EWS-FLI-1 target whose suppression is implicated in ESFT development. Here, we use miRNA arrays to compare the global miRNA expression profile of human mesenchymal stem cells (MSC) and ESFT cell lines, and show that ESFT display a distinct miRNA signature that includes induction of the oncogenic miRNA 17-92 cluster and repression of the tumor suppressor let-7 family. We demonstrate that direct repression of let-7a by EWS-FLI-1 participates in the tumorigenic potential of ESFT cells in vivo. The mechanism whereby let-7a expression regulates ESFT growth is shown to be mediated by its target gene HMGA2, as let-7a overexpression and HMGA2 repression both block ESFT cell tumorigenicity. Consistent with these observations, systemic delivery of synthetic let-7a into ESFT-bearing mice restored its expression in tumor cells, decreased HMGA2 expression levels and resulted in ESFT growth inhibition in vivo. Our observations provide evidence that deregulation of let-7a target gene expression participates in ESFT development and identify let-7a as promising new therapeutic target for one of the most aggressive pediatric malignancies